
Cepheid
Total Raised
$58.45MInvestors Count
13Deal Terms
2Funding, Valuation & Revenue
7 Fundings
Cepheid has raised $58.45M over 7 rounds.
Cepheid's latest funding round was a Grant for $28M on July 30, 2021.
Cepheid's valuation in November 2016 was $4,000M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/30/2021 | Grant | $28M | 1 | |||
11/5/2016 | Acq - P2P | $4,000M | ||||
6/21/2000 | IPO | |||||
1/6/2000 | Series C | |||||
4/13/1998 | Series B |
Date | 7/30/2021 | 11/5/2016 | 6/21/2000 | 1/6/2000 | 4/13/1998 |
|---|---|---|---|---|---|
Round | Grant | Acq - P2P | IPO | Series C | Series B |
Amount | $28M | ||||
Investors | |||||
Valuation | $4,000M | ||||
Revenue | |||||
Sources | 1 |
Cepheid Deal Terms
2 Deal Terms
Cepheid's deal structure is available for 2 funding rounds, including their Acq - P2P from November 05, 2016.
Round | Acq - P2P | Series B |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
Series B |
Cepheid Investors
13 Investors
Cepheid has 13 investors. US Department of Health and Human Services invested in Cepheid's Grant funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/30/2021 | 7/30/2021 | 1 Grant | Government | DC | ||
11/5/2016 | 11/5/2016 | 1 Acq - P2P | Corporation | DC | ||
4/13/1998 | 1/6/2000 | 2 Series B, Series C (2000) | Investment Bank | New York | ||
Corporation | Minnesota | |||||
Corporation | Belgium |
First funding | 7/30/2021 | 11/5/2016 | 4/13/1998 | ||
|---|---|---|---|---|---|
Last Funding | 7/30/2021 | 11/5/2016 | 1/6/2000 | ||
Investor | |||||
Rounds | 1 Grant | 1 Acq - P2P | 2 Series B, Series C (2000) | ||
Board Seats | |||||
Type | Government | Corporation | Investment Bank | Corporation | Corporation |
Location | DC | DC | New York | Minnesota | Belgium |
Cepheid Acquisitions
2 Acquisitions
Cepheid acquired 2 companies. Their latest acquisition was OncoMark on December 16, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/16/2021 | Other | $9.9M | Acquired | 4 | ||
10/3/2014 |
Date | 12/16/2021 | 10/3/2014 |
|---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | $9.9M | |
Note | Acquired | |
Sources | 4 |
Compare Cepheid to Competitors
Mimark focuses on the development of diagnostic solutions for gynecological diseases within the healthcare sector. The company provides a diagnostic approach that utilizes gynecological fluids to assist in the diagnosis of gynecological conditions. Their main products include GyLDEC for endometrial cancer diagnosis and GyLDENDO for endometriosis diagnosis, both of which are based on protein biomarker analysis and designed to be less invasive. It was founded in 2021 and is based in Barcelona, Spain.

Ontera specializes in the development of silicon nanopore chips and proprietary biochemistry for the life sciences industry. The company's main offerings include tools for the detection and differentiation of single molecules, which are important for point-of-care testing and third generation sequencing. Ontera primarily serves sectors that require diagnostic and sequencing solutions. Ontera was formerly known as Two Pore Guys. It was founded in 2011 and is based in Bangkok, Thailand.

Thermo Fisher Scientific serves the science sector with a range of products and services. The company offers scientific research tools, biotechnology products, and diagnostic testing equipment, as well as laboratory and pharmaceutical development services. Thermo Fisher Scientific serves the biotech, biopharma, contract development and manufacturing organization (CDMO), lab diagnostics, and industrial and applied sciences sectors. Thermo Fisher Scientific was formerly known as Thermo Electron. It was founded in 2006 and is based in Waltham, Massachusetts.

PerkinElmer operates as a provider of technology and service solutions in the laboratory sector, focusing on food, industrial, life sciences, and environmental markets. The company offers a range of products and services, including laboratory technologies for analysis and characterization, atomic spectroscopy, chromatography, and food quality analyzers. PerkinElmer's solutions help customers evaluate the quality and safety of products. It was founded in 1937 and is based in Shelton, Connecticut.
Meterbolic conducts metabolic health assessments and preventive healthcare within the medical diagnostics sector. The company offers tests that measure insulin response and other metabolic markers to predict the risk of diabetes and other chronic diseases, which can assist in health management. Meterbolic serves individuals seeking health monitoring and those interested in preventive healthcare. It was founded in 2018 and is based in London, United Kingdom.

Color specializes in genetic testing and health services. It focuses on early detection and management of cancer and hereditary diseases. The company offers genetic screenings to assess the risk for hereditary cancer and heart conditions, as well as services to understand medication responses, aiming to facilitate preventative health measures and personalized care plans. Color primarily serves employers, health plans, unions, and clinicians, providing them with tools to manage the health of their populations. Color was formerly known as Color Genomics. It was founded in 2014 and is based in Burlingame, California.
Loading...

